We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$612B
AUM Growth
+$90.2B
Cap. Flow
-$9.31B
Cap. Flow %
-1.52%
Top 10 Hldgs %
32.09%
Holding
12,204
New
1,722
Increased
4,580
Reduced
4,534
Closed
1,264

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$703M
2
BAC icon
Bank of America
BAC
+$690M
3
AMZN icon
Amazon
AMZN
+$678M
4
JPM icon
JPMorgan Chase
JPM
+$601M
5
META icon
Meta Platforms (Facebook)
META
+$431M

Sector Composition

Rank Sector Weight
1 Technology 2.38%
2 Consumer Discretionary 1.48%
3 Healthcare 0.92%
4 Communication Services 0.78%
5 Financials 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSG
10776
DELISTED
Overseas Shipholding Group Inc.
OSG
$30K ﹤0.01%
+13,939
New +$29K
SRGA
10777
PUT
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$30K ﹤0.01%
+450
New +$29.3K
BCIC
10778
CALL
BCP Investment Corp
BCIC
$95M
$29K ﹤0.01%
+1,510
New +$22.8K
XIN
10779
DELISTED
Xinyuan Real Estate
XIN
$29K ﹤0.01%
1,317
-1,915
-59% -$41.5K
AGRX
10780
PUT
DELISTED
Agile Therapeutics
AGRX
$29K ﹤0.01%
5
-25
-83% -$147K
NAVB
10781
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$29K ﹤0.01%
+13,388
New +$31.6K
FENG
10782
CALL
Phoenix New Media
FENG
$17.8M
$28K ﹤0.01%
+3,950
New +$41.4K
FENG
10783
Phoenix New Media
FENG
$17.8M
$28K ﹤0.01%
+3,927
New +$41.1K
LSTA icon
10784
PUT
Lisata Therapeutics
LSTA
$16.3M
$28K ﹤0.01%
1,287
-2,146
-63% -$50.9K
NERV icon
10785
CALL
Minerva Neurosciences
NERV
$259M
$28K ﹤0.01%
1,488
-2,150
-59% -$54.2K
SLNO
10786
CALL
DELISTED
Soleno Therapeutics
SLNO
$28K ﹤0.01%
967
-5,066
-84% -$146K
ABTS icon
10787
Abits Group
ABTS
$4.24M
$27K ﹤0.01%
+1,302
New +$24.5K
CANF
10788
Can-Fite BioPharma American Depositary Shares
CANF
$7.11M
$27K ﹤0.01%
+77
New +$28.1K
CKPT
10789
DELISTED
Checkpoint Therapeutics
CKPT
$27K ﹤0.01%
+1,002
New +$25.4K
TOPS icon
10790
TOP Ships
TOPS
$4.44M
$27K ﹤0.01%
+92
New +$25.9K
CHS
10791
CALL
DELISTED
Chicos FAS, Inc.
CHS
$26K ﹤0.01%
+16,200
New +$22.5K
BXRX
10792
PUT
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$26K ﹤0.01%
19
-45
-70% -$92.1K
BTOG icon
10793
Bit Origin
BTOG
$2.85M
$25K ﹤0.01%
3
+1
+50% +$7.57K
GPL
10794
DELISTED
Great Panther Mining Limited
GPL
$25K ﹤0.01%
2,936
-6,359
-68% -$53.3K
YDKG
10795
Yueda Digital Holding
YDKG
$5.7M
$24K ﹤0.01%
+27
New +$12.6K
TLSA icon
10796
CALL
Tiziana Life Sciences
TLSA
$139M
$24K ﹤0.01%
+12,000
New +$37.9K
HYMCZ
10797
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$24K ﹤0.01%
64,844
+18,449
+40% +$5.59K
PTE
10798
CALL
DELISTED
PolarityTE, Inc. Common Stock
PTE
$24K ﹤0.01%
1,432
-2,076
-59% -$43.9K
MTL.PR
10799
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$24K ﹤0.01%
48,567
-131,203
-73% -$57K
IMNN icon
10800
CALL
Imunon
IMNN
$9.15M
$23K ﹤0.01%
165
-71
-30% -$8.51K

Similar funds

Jeff Yass's Q4 2020 Portfolio in Review

As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
  • Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
  • Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
  • Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
  • Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
  • Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.